COMMUNIQUÉS West-GlobeNewswire

Tower One Provides Update on South American Operations
11/07/2018
VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTC:TOWTF) (Frankfurt:1P3N) (“Tower One” or the “Company”) announces a comprehensive update on recent company milestones [...]
Oncobiologics Regains Compliance with Applicable Nasdaq Listing Requirements
11/07/2018
CRANBURY, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (Nasdaq:ONS) today announced that, on July 10, 2018, the Company received formal notice from The Nasdaq Stock Market LLC that the Company has [...]
RXB Healthcare Technologies Enters European Market with Acquisition of SPR Global Technologies
11/07/2018
VANCOUVER, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- RXB Healthcare Technologies Ltd. (the "Company" or "RXB Healthcare") is pleased to announce that it has entered into an agreement to acquire SPR Global [...]
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
11/07/2018
OXNARD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet with Therapix [...]
Teladoc to Announce Second Quarter 2018 Financial Results
11/07/2018
PURCHASE, NY, July 11, 2018 (GLOBE NEWSWIRE) -- Teladoc , Inc. (NYSE:TDOC), the global leader in virtual care, announced today that it will release second quarter 2018 results on Wednesday, August 1, 2018, after the [...]
Yield10 Bioscience Names Dr. Jay J. Thelen, Ph.D. to Scientific Advisory Board
11/07/2018
WOBURN, Mass., July 11, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-changes in yield for major food and feed crops to enhance global food [...]
Vilacto Bio Focuses Resources On Pharmaceutical Opportunities for LACTOACTIVE iTHER®
11/07/2018
COPENHAGEN, Denmark, July 11, 2018 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTCQB:VIBI) plans to focus on its new pharmaceutical product, LACTOACTIVE iTHER®, as another potential revenue stream for the company along with [...]
Lumiata Raises $11 Million to Accelerate AI Powered Health Analytics for Improving Healthcare, Introduces CEO Dilawar Syed
11/07/2018
Funding from Khosla Ventures, BlueCross BlueShield Venture Partners, and Intel Capital to fuel transformation of healthcare across insurers, providers and employers through predictive analytics SAN MATEO, Calif., July [...]
UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGel™) for the Treatment of Low-Grade Non-Muscle Invasive Bladder Cancer (LG NMIBC)
11/07/2018
Company Expects to Begin U.S. Phase 2b Clinical Trial in Q3 2018 UGN-102 Has Potential to Become the First Front Line Non-Surgical Therapy for Patients with LG NMIBC RA’ANANA, Israel and NEW YORK, July 11, 2018 (GLOBE [...]
BioSig Technologies to Present at the 40th International Conference of the IEEE Engineering in Medicine and Biology Society
11/07/2018
Research Poster “Unipolar Intracardiac Signal Morphology as a Parameter for Catheter Contact Evaluation” to be presented at EMBC ‘18 on July 18 in Honolulu, Hawaii Santa Monica, CA, July 11, 2018 (GLOBE NEWSWIRE) -- [...]
Melinta Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018
11/07/2018
NEW HAVEN, Conn., July 11, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
Atlant Clinical to receive ISO 9001:2015 certification in Organization and Management of Clinical Trials (issued by Bureau Veritas)
11/07/2018
RIDGEWOOD, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Atlant Clinical has proven its reputation to be among the world’s top quality CROs by receiving ISO 9001:2015 certification in Organization and Management of Clinical [...]
Moleculin Expands Operations to Australia; Taps R&D Incentive Program Capped at $20,000,000 AUD Turnover
11/07/2018
HOUSTON, July 11, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Corium Announces Issuance of Additional U.S. Patent Covering Corplex™ Donepezil Transdermal System for Alzheimer’s Disease
11/07/2018
Second Orange Book Listable Patent Provides Expanded Coverage to 2037 MENLO PARK, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI), a commercial stage biopharmaceutical company focused [...]
Ovid Therapeutics Announces Initiation of Phase 2 ROCKET Clinical Trial to Evaluate OV101 in Fragile X Syndrome
11/07/2018
Phase 2 trial will evaluate OV101 for 12 weeks in up to 30 males aged 13 to 22 NEW YORK, July 11, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing [...]
Akcea and Ionis Announce Approval of TEGSEDI™ (inotersen) in the European Union
11/07/2018
CAMBRIDGE, Mass. and CARLSBAD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., and Ionis Pharmaceuticals, Inc. (NASDAQ:IONS), announced [...]
OCHWW looks to the future with appointment of new chief creative officer, Samantha Dolin
11/07/2018
PARSIPPANY, N.J., July 11, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide (OCHWW; www.ogilvychww.com ), a WPP Health & Wellness company (NYSE:WPP) ( www.wpp.com ), announced today that industry-renowned [...]
Asterias Biotherapeutics Announces Positive Outcome from Safety Review Committee for AST-VAC2; Recommends Continuation of Clinical Trial in Non-Small Cell Lung Cancer (NSCLC)
11/07/2018
FREMONT, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American:AST), a biotechnology company dedicated to developing cellular immunotherapies to treat cancer and cell-based therapeutics [...]
Cara Therapeutics Announces Dosing of Patients in Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Stage III-V Chronic Kidney Disease (CKD) Patients
11/07/2018
Completed Phase 1 trial establishes Oral KORSUVA tablet strengths for treatment of CKD-associated pruritus STAMFORD, Conn., July 11, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical [...]

Pages